Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.41 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.32 |
| ▸ | HTR1A | P08908 | 1/20 | 0.31 |
| ▸ | DRD2 | P14416 | 1/20 | 0.31 |
| ▸ | HTR2A | P28223 | 1/20 | 0.31 |
| ▸ | HTR2C | P28335 | 1/20 | 0.31 |
| ▸ | DRD3 | P35462 | 1/20 | 0.31 |
| ▸ | HTR6 | P50406 | 1/20 | 0.31 |
| ▸ | MYC | P01106 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16420342 | 0.90 | KDM4E (0.49) | KDM4EALDH1A1GAAHPGDALOX12 | |
| SCHEMBL16420323 | 0.84 | KDM4E (0.40) | KDM4EALDH1A1GAAHPGDALOX12 | |
| SCHEMBL16709150 | 0.83 | KDM4E (0.44) | KDM4EALDH1A1GAAHPGDALOX12 | |
| SCHEMBL17655191 | 0.83 | KDM4E (0.44) | KDM4EALDH1A1GAAHPGDALOX12 | |
| SCHEMBL16420365 | 0.80 | ALDH1A1 (0.37) | KDM4EALDH1A1GAAHPGDALOX12 | |
| SCHEMBL16420346 | 0.80 | ALDH1A1 (0.39) | KDM4EALDH1A1GAAHPGDALOX12 | |
| SCHEMBL16420353 | 0.80 | KDM4E (0.40) | KDM4EALDH1A1GAAHPGDALOX12 | |
| SCHEMBL26275300 | 0.80 | KDM4E (0.59) | KDM4EALDH1A1GAAHPGDALOX12 | |
| SCHEMBL16420314 | 0.78 | KDM4E (0.35) | KDM4EALDH1A1GAAHPGDALOX12 | |
| SCHEMBL17131424 | 0.78 | KDM4E (0.35) | KDM4EALDH1A1GAAHPGDALOX12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170250354-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2017-08-31 | — | — | US | disclosed |
| US-20150028290-A1 | HETEROLEPTIC OSMIUM COMPLEX AND METHOD OF MAKING THE SAME | UNIVERSAL DISPLAY CORPORATION (US) | 2015-01-29 | — | — | US | disclosed |
| US-20150028290-A1 | HETEROLEPTIC OSMIUM COMPLEX AND METHOD OF MAKING THE SAME | UNIVERSAL DISPLAY CORPORATION (US) | 2015-01-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170250354-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OSBPL3, OR10J3, OSBP2 | KDM4E 3560/4885ALDH1A1 1215/4885GAA 4541/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.